The S&P/ASX 200 Index (ASX: XJO) continued its recent slump on Monday. This included a heavy sell-off for many well-known ASX shares that hit fresh 52-week lows.
Three ASX shares hitting new yearly lows were:
- Brambles Ltd (ASX: BXB) crashed 20%
- Sonic Healthcare Ltd (ASX: SHL) dropped a further 2%
- Amcor Plc (ASX: AMC) fell 4%.
For investors holding positions in these companies, it can be difficult not to panic when shares hit 52-week lows.
For investors on the outside looking in, it can be an opportunity to find value in quality stocks.
Let's see what experts are saying.
Image source: Getty Images
Brambles crashes on trading update
Brambles is the world's largest supplier of reusable wooden pallets and crates used for storing and transporting goods.
It operates in more than 60 countries, primarily under the Chep brand. The company touts itself as a pioneer of the 'sharing economy', managing a reusable pool of pallets and containers to service global supply chains and logistics.
Yesterday, it released a FY26 trading update.
It revealed revised FY26 guidance and the announcement of a new US$400 million share buy-back.
Brambles now expects sales revenue growth of 2% to 3% (previously 3% to 4%) and underlying profit growth of 3% to 5% (from 8% to 11%).
This news sent investors running for the hills, as the share price crashed 20% to a new 52-week low of $17.63.
It may be a buy-low candidate after the crash.
The team at Jarden recently placed an overweight rating and $25.15 price target on Brambles shares.
It's worth noting this was prior to the recent guidance downgrade.
Sonic Healthcare continues its slump
Sonic Healthcare is a global healthcare provider. It is the largest private medical laboratory and pathology services operator in Australia, the United Kingdom, Germany, and Switzerland.
It hit new 52-week lows yesterday closing at $18.39.
Its share price is now down 18% year to date.
It does have appeal as a dividend stock, as well as some capital upside.
16 analyst forecasts via TradingView place an average price target of $24.25 on this ASX healthcare stock.
That indicates roughly 30% upside from current levels.
Amcor continues to slide
Amcor operates as a holding company, which engages in the consumer packaging business.
It has struggled so far in 2026, falling 4% yesterday to take its year to date fall to roughly 18%.
It recently released 3Q26 earnings which were largely in line with expectations.
The team at Morgans is optimistic this ASX stock can bounce back from fresh 52-week lows.
The broker recently lowered its price target to $65.40 (from $68.20), however maintained its buy recommendation.
From yesterday's closing price of $51.44, this updated target indicates an upside potential of 27%.
